Cargando…
Curcumin therapy in a Plp1 transgenic mouse model of Pelizaeus-Merzbacher disease
OBJECTIVE: Pelizaeus–Merzbacher disease (PMD) is a progressive and lethal leukodystrophy caused by mutations affecting the proteolipid protein (PLP1) gene. The most common cause of PMD is a duplication of PLP1 and at present there is no curative therapy available. METHODS: By using transgenic mice c...
Autores principales: | Epplen, Dirk B, Prukop, Thomas, Nientiedt, Tobias, Albrecht, Philipp, Arlt, Friederike A, Stassart, Ruth M, Kassmann, Celia M, Methner, Axel, Nave, Klaus-Armin, Werner, Hauke B, Sereda, Michael W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4554440/ https://www.ncbi.nlm.nih.gov/pubmed/26339673 http://dx.doi.org/10.1002/acn3.219 |
Ejemplares similares
-
Demyelination and axonal preservation in a transgenic mouse model of Pelizaeus-Merzbacher disease
por: Edgar, Julia M, et al.
Publicado: (2010) -
Drug screening for Pelizaeus-Merzbacher disease by quantifying the total levels and membrane localization of PLP1
por: Kouga, Takeshi, et al.
Publicado: (2019) -
Pelizaeus-Merzbacher disease in siblings
por: Mittal, Amit, et al.
Publicado: (2010) -
Neural stem cells restore myelin in a demyelinating model of Pelizaeus-Merzbacher disease
por: Gruenenfelder, Fredrik I, et al.
Publicado: (2020) -
The natural history of Pelizaeus–Merzbacher disease caused by PLP1 duplication: A multiyear case series
por: Trepanier, Angela M., et al.
Publicado: (2023)